High-Dose Vitamin C Doubles Pancreatic Cancer Patient Survival Rates: Clinical Trial

Life expectancy with chemotherapy alone is eight months, while adding high-dose intravenous vitamin C resulted in 16 months of survival.

Capture_The_World/Shutterstock

Adding high-dose vitamin C to a cancer treatment regimen may double survival time, according to a clinical trial that tested this in pancreatic cancer patients.

Typically diagnosed in its advanced stages, pancreatic cancer has a poor prognosis and leaves patients with limited treatment options, with most surviving only eight months with standard chemotherapy.